Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022; No adverse event; Bivalent vaccine were administered to patients after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) in an 80-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Hepatitis A on 11-Nov-1942, MMR on 17-Nov-2006, Pneumococcal adult on 12-Jul-2011, Tdap on 29-Jun-2012, Pneumococcal adult on 16-Sep-2015, Seasonal influenza on 19-Oct-2016, Seasonal influenza on 20-Oct-2017, Seasonal influenza on 10-Aug-2018, Seasonal influenza on 09-Sep-2019, Zoster on 09-Sep-2019, Zoster on 17-Jan-2020, INFLUENZA VACCINE on 15-Oct-2020, Sars-Cov-2 on 27-Feb-2021, Sars-Cov-2 on 27-Mar-2021, Seasonal influenza on 20-Oct-2021, Sars-Cov-2 on 17-Nov-2021, Hepatitis B on 01-Apr-2022 and Seasonal influenza on 30-Aug-2022. Past adverse reactions to the above products included No adverse event with Hepatitis A, Hepatitis B, INFLUENZA VACCINE, MMR, Pneumococcal adult, Pneumococcal adult, Sars-Cov-2, Sars-Cov-2, Sars-Cov-2, Seasonal influenza, Seasonal influenza, Seasonal influenza, Seasonal influenza, Seasonal influenza, Seasonal influenza, Tdap, Zoster and Zoster.    On 30-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 30-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022).    No concomitant medications were reported. Vial size was 2.5 ml. Date the vial was initially stored in the refrigerator was 29-Sep-2022. The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022.The vial didn't undergo any temperature excursions. No treatment information was provided.